摘要
目的分析在肝切除治疗梗阻型肝胆管结石患者中应用阿托伐他汀的效果。方法回顾分析2013年1月—2017年8月在我单位采用肝切除治疗梗阻型肝胆管结石患者58例临床资料,根据患者住院中是否使用阿托伐他汀分组,研究组30例,使用阿托伐他汀,对照组28例,未使用阿托伐他汀,对比两组患者术后肝功能情况和治疗效果。结果研究组术后1周肝功能指标均低于对照组,与对照组比较存在明显差异(P<0.05),研究组患者并发症总发生率与对照组比较不具有统计学差异(P>0.05),研究组术后住院时间短于对照组,与对照组比较存在统计学差异(P<0.05)。结论阿托伐他汀在肝切除治疗梗阻型肝胆管结石患者中,对肝功能恢复具有促进作用,并且缩短住院时间,有利于患者的术后康复。
Objective To analyze the effect of atorvastatin in patients with hepatolithiasis in the treatment of obstructive hepatolithiasis. Methods A retrospective analysis from January 2013 to August 2017 in our unit treated by hepatectomy in patients with obstructive intrahepatic biliary calculi in 58 cases, according to whether the use of atorvastatin atorvastatin in patients group, the study group of 30 cases, they used atorvastatin, 28 cases in the control group did not use atorvastatin, the effect of liver function and treatment were compared between two patients after surgery. Results 1 week postoperative liver function indexes in the study group were lower than the control group, there were obvious differences compared with the control group （P〈0.05）, the total incidence rate of complications in study group compared with the control group no statistically significant difference （P 〉0.05）, postoperative hospital stay in the study group was shorter than the control group, there was significant difference （P〈0.05）. Conclusion Atorvastatin can promote liver function recovery in patients with obstructive hepatolithiasis after hepatectomy, and shorten the length of hospital stay, which is conducive to postoperative rehabilitation.
出处
《中国卫生标准管理》
2017年第28期97-99,共3页
China Health Standard Management
